Almac and DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM N.V., have entered into a collaboration agreement to provide sustainable manufacturing services in the field of biocatalysis.   The agreement grants both parties access to their enzyme platform technologies and services for the manufacture of APIs. Almac will leverage its expertise in rapid enzyme identification, scale-up and implementation into early phase projects, and DSM will leverage its exp...